Krueger Christopher W's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Apr 5, 2023
- Accession no.
- 0001209191-23-023472
- Filed
- Apr 5, 2023
- Trade date
- Apr 3, 2022-Apr 3, 2023
- Filing delay
- 367 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $493.2K. It was filed 367 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001209191-23-027314 (May 4, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krueger Christopher WCIK 0001394208 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2022 | Common Stock | MOption exerciseAcquired | +7,972 | $3.54 | +$28,220.88 | 290,642 | Direct | |
| Apr 3, 2022 | Common Stock | MOption exerciseAcquired | +475 | $8.04 | +$3,819 | 291,117 | Direct | |
| Apr 3, 2022 | Common Stock | SSaleDisposed | −15,000 | $32.88F2 | −$493,200 | 276,117 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −7,972 | $0.00 | $0 | 0 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −475 | $0.00 | $0 | 170,176 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 15,000 shares sold in the price range of $32.5744 to $33.495. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.